Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Germany / NCT01055093
Recruiting Observational

Prospective Study on Diabetes Mellitus and Its Complications in Newly Diagnosed Adult Patients

NCT01055093 · tracked via the Priya Life Science Germany tracker
Sponsor
German Diabetes Center
Phase
Observational
Started
2005-09
Last updated
2025-07-16

Condition(s) studied

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Study summary

The aim of the prospective observational GDC-Study in patients with newly diagnosed diabetes mellitus aged 18-69 years at inclusion into the study is to characterize in detail the clinical, metabolical and immunological phenotype and monitor the progression of the disease and to compare the phenotype to glucose tolerant humans of similar age, body mass and sex distribution.

Eligibility

Sex
ALL
Min age
18 Years
Max age
69 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Clinical diagnosis of diabetes mellitus according to ADA criteria * Age 18-69 * Diabetes duration since diagnosis \< 12 months * Control cohort: proven normal glucose tolerance according to ADA criteria Exclusion Criteria: * Diabetes mellitus category 3 B-H (ADA criteria) * Pregnancy * Severe renal, liver or heart disease * malignant cancer * severe psychiatric illness or addiction * participation in an intervention trial

Primary outcome measure(s)

  • Change of insulin sensitivity (M-Value) — 2 and 5 years
    measurement of whole body insulin sensitivity with hyperinsulinamic euglicamic clamp

Trial sites (1)

FacilityCityRegionStatus
German Diabetes Center Düsseldorf North Rhine-Westphalia Recruiting

More German Diabetes Center trials in Germany

The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism Recruiting
Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI Recruiting
Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE) Recruiting
Overfeeding Induced Fat-tissue Stimulation Recruiting
"Hepatic Substrate Flux Rates in Type 2 Diabetes" Active, not recruiting

Other trials for the same condition

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes Starting soon
A Study to See the Effect of NNC0194-0499 Alone or in Combination With Semaglutide on Blood Sugar Control in People Living With Type 1 Diabetes Active, not recruiting
Cohort Study on Plant-based Diets (COPLANT Study) Recruiting
The Effect of Bariatric Surgery on Insulin Sensitivity and Energy Metabolism Recruiting
A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01055093 on ClinicalTrials.gov ↗ ← All trials in Germany